Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) improved in recent days. AZN’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
Astrazeneca PLC (NASDAQ: AZN) stock declined slightly by -0.5% on 2/7/25. The stock closed at $71.99. Trading volume in this decline was normal. The stock has been weak relative to the market over the last nine months but has risen 1.1% during the last week.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of C (High Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Astrazeneca has a very high Appreciation Score of 88 but a slightly negative Power Rating of 32, triggering the High Neutral Value Trend Rating.
Be the first to comment